Jonathan D. Root, Director at Silverback Therapeutics, Inc. (SBTX), bought 109,915 shares at $21.00 ($2.0M) on 2020-12-08, disclosed to the SEC on 2020-12-08.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 14,677 | $0 | 0.0% |
| 2 | $21.00 | 95,238 | $2.0M | 100.0% |
| Total | $18.20 avg | 109,915 | $2.0M | 100% |
| Filing → |
| SBTX | BUY | 2022-03-18 | $36K | — | Filing → |
| NARI | BUY | 2022-03-18 | $28K | — | Filing → |
| EFTR | SELL | 2021-12-06 | $46K | — | Filing → |